Image

    Alopecia Areata: Current Concepts

    Audrey Terrany, Robert A. Schwartz
    Studysummary This review highlights advancements in the understanding and treatment of alopecia areata, noting that the approval of oral Janus kinase inhibitors like baricitinib and ritlecitinib marks a significant development in managing severe cases of this autoimmune condition.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 47

    1. Treatment Outcomes and Considerations for Topical Immunotherapy in Patients with Alopecia Totalis and Alopecia Universalis Frontiers in Medicine · 2025
    2. Global Burden of Alopecia Areata from 1990 to 2019 and Emerging Treatment Trends Analyzed Through GBD 2019 and Bibliometric Data Scientific Reports · 2025
    3. Immune-Mediated Disorders in Patients With Alopecia Areata: Systematic Review and Meta-Analysis International Journal of Dermatology · 2025
    4. Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents With Alopecia Areata Dermatology and Therapy · 2025
    5. Assessment of Alopecia Areata Disease Severity in Pediatric Patients Pediatric Dermatology · 2025
    6. Familial Patterns of Alopecia Areata: A Systematic Review and Meta-Analysis Journal of Autoimmunity · 2025
    7. Case Report: Baricitinib Improved Alopecia Areata in a Pediatric Patient with Atopic Dermatitis Frontiers in Pediatrics · 2025
    8. The Role of Minoxidil in the Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis Journal of Clinical Medicine · 2024
    9. II Consensus of the Brazilian Society of Dermatology for the Treatment of Alopecia Areata Anais Brasileiros de Dermatologia · 2024
    10. Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia Life · 2024
    11. Real-Life Effectiveness and Safety of Baricitinib in Patients with Severe Alopecia Areata: A 24-Week Italian Study Journal of the European Academy of Dermatology and Venereology · 2024
    12. Assessing a Measure for Quality of Life in Patients with Severe Alopecia Areata: A Multicentric Italian Study Frontiers in Public Health · 2024
    13. Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata JAMA Dermatology · 2024
    14. Case Report: Sequential Therapy with Dupilumab and Baricitinib for Severe Alopecia Areata with Atopic Dermatitis in Children Frontiers in immunology · 2024
    15. Alopecia Areata of the Nails: Diagnosis and Management Journal of Clinical Medicine · 2024
    16. Comparative Efficacy and Safety of JAK Inhibitors in the Treatment of Moderate-to-Severe Alopecia Areata: A Systematic Review and Network Meta-Analysis Frontiers in pharmacology · 2024
    17. Clinical And Demographic Characteristics Associated With Nail Involvement In Alopecia Areata: A Cross-Sectional Study Of 197 Patients Health Science Reports · 2024
    18. Efficacy and Adverse Effects of Corticosteroid Pulse Therapy in Alopecia Areata Dermatology practical & conceptual · 2023
    19. Screening for Latent Infectious Disease in Patients with Alopecia Areata Before Initiating JAK Inhibitors Therapy: A Single-Center Real-World Retrospective Study Frontiers in medicine · 2023
    20. Comorbid Conditions Associated With Alopecia Areata: A Systematic Review and Meta-Analysis American Journal of Clinical Dermatology · 2023
    21. Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata: A Randomised, Double-Blind, Multicentre, Phase 2b–3 Trial The Lancet · 2023
    22. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population JAMA Dermatology · 2023
    23. Quality of Life in Children and Adolescents With Alopecia Areata: A Systematic Review Journal of the European Academy of Dermatology and Venereology · 2023
    24. An Update on Alopecia and Its Association With Thyroid Autoimmune Diseases European endocrinology · 2023
    25. Ideal JAK Inhibitor for Alopecia Areata: Baricitinib, Tofacitinib, Ritlecitinib, or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway Indian Dermatology Online Journal · 2023
    26. The Association of Alopecia Areata-Related Emotional Symptoms with Work Productivity and Daily Activity Among Patients with Alopecia Areata Dermatology and Therapy · 2022
    27. Healthcare Utilization And Costs Among US Adolescents With Alopecia Areata Journal of health economics and outcomes research · 2022
    28. Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implications of Post-Translational Modifications Frontiers in immunology · 2022
    29. Low Level Laser Versus Platelet-Rich Plasma in Treatment of Alopecia Areata: A Randomized Controlled Intra-Patient Comparative Study Open Access Macedonian Journal of Medical Sciences · 2022
    30. Microneedling for Hair Loss Journal of Cosmetic Dermatology · 2021
    31. A Retrospective Comparative Study of Two Concentrations of Intralesional Triamcinolone Acetonide in the Treatment of Patchy Alopecia Areata on the Scalp Clinical Cosmetic and Investigational Dermatology · 2020
    32. Female Pattern Hair Loss: A Comprehensive Review Dermatologic Therapy · 2020
    33. Low-Dose Oral Minoxidil as Treatment for Non-Scarring Alopecia: A Systematic Review International Journal of Dermatology · 2020
    34. The Alopecia Areata Investigator Global Assessment Scale: A Measure for Evaluating Clinically Meaningful Success in Clinical Trials British Journal of Dermatology · 2020
    35. Efficacy of Different Concentrations of Intralesional Triamcinolone Acetonide for Alopecia Areata: A Systematic Review and Meta-Analysis Journal of the American Academy of Dermatology · 2019
    36. Evaluation of Platelet-Rich Plasma vs Intralesional Steroid in Treatment of Alopecia Areata Journal of Cosmetic Dermatology · 2019
    37. Cyclosporine for Moderate-to-Severe Alopecia Areata: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety Journal of the American Academy of Dermatology · 2019
    38. Overnight Alopecia: A Subtype of Acute Diffuse and Total Alopecia? International Journal of Trichology · 2019
    39. Association of Alopecia Areata with Atopic Dermatitis and Chronic Spontaneous Urticaria Allergy and asthma proceedings · 2018
    40. Nail Involvement in Alopecia Areata: A Questionnaire-Based Survey on Clinical Signs, Impact on Quality of Life, and Review of the Literature 2018
    41. Understanding Autoimmunity of Vitiligo and Alopecia Areata Current opinion in pediatrics, with evaluated MEDLINE/Current opinion in pediatrics · 2016
    42. Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition Nature medicine · 2014
    43. Dermatoscopy: Alternative Uses in Daily Clinical Practice 2011
    44. Utility of Dermoscopy in Alopecia Areata Indian Journal of Dermatology/Indian journal of dermatology · 2011
    45. Genome-Wide Association Study in Alopecia Areata Implicates Both Innate and Adaptive Immunity Nature · 2010
    46. Comma Hairs: A Dermatoscopic Marker for Tinea Capitis Journal of The American Academy of Dermatology · 2008
    47. Maintenance of Hair Follicle Immune Privilege Is Linked to Prevention of NK Cell Attack Journal of Investigative Dermatology · 2007